What is the official website of Proxycare Pharmacy ?

The official website of Proxycare Pharmacy is http://proxycarerx.com.

What is Proxycare Pharmacy's cybersecurity risk score?

Proxycare Pharmacy has an AI-generated cybersecurity risk score of 696 out of 1000, indicating a Weak security posture according to Rankiteo's assessment.

How many security incidents has Proxycare Pharmacy experienced?

According to Rankiteo, Proxycare Pharmacy currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Proxycare Pharmacy been affected by any supply chain cyber incidents ?

According to Rankiteo, Proxycare Pharmacy has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Proxycare Pharmacy have SOC 2 Type 1 certification ?

According to Rankiteo, Proxycare Pharmacy is not certified under SOC 2 Type 1.

Does Proxycare Pharmacy have SOC 2 Type 2 certification ?

According to Rankiteo, Proxycare Pharmacy does not hold a SOC 2 Type 2 certification.

Does Proxycare Pharmacy comply with GDPR ?

According to Rankiteo, Proxycare Pharmacy is not listed as GDPR compliant.

Does Proxycare Pharmacy have PCI DSS certification ?

According to Rankiteo, Proxycare Pharmacy does not currently maintain PCI DSS compliance.

Does Proxycare Pharmacy comply with HIPAA ?

According to Rankiteo, Proxycare Pharmacy is not compliant with HIPAA regulations.

Does Proxycare Pharmacy have ISO 27001 certification ?

According to Rankiteo,Proxycare Pharmacy is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Proxycare Pharmacy operate in ?

Proxycare Pharmacy operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Proxycare Pharmacy have ?

Proxycare Pharmacy employs approximately 6 people worldwide.

Does Proxycare Pharmacy own any subsidiaries ?

Proxycare Pharmacy presently has no subsidiaries across any sectors.

How many LinkedIn followers does Proxycare Pharmacy have ?

Proxycare Pharmacy's official LinkedIn profile has approximately 18 followers.

What is the NAICS classification code for Proxycare Pharmacy ?

Proxycare Pharmacy is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Proxycare Pharmacy have a Crunchbase profile ?

No, Proxycare Pharmacy does not have a profile on Crunchbase.

Does Proxycare Pharmacy have a LinkedIn profile ?

Yes, Proxycare Pharmacy maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/proxycare-pharmacy.

How many cybersecurity incidents has Proxycare Pharmacy experienced ?

As of September 30, 2026, Rankiteo reports that Proxycare Pharmacy has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Proxycare Pharmacy have ?

Proxycare Pharmacy has an estimated 5,771 peer or competitor companies worldwide.

What types of cybersecurity incidents has Proxycare Pharmacy faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Proxycare Pharmacy

Boost Score +25 with badge (5 left)

696

/1000

Weak

721

/1000

Moderate

Proxycare Pharmacy Vendor Cyber Rating & Cyber Score

proxycarerx.com

Add Your Compliance Badge

Long Term Health Pharmacy Solitions

Proxycare Pharmacy

Proxycare Pharmacy CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Proxycare Pharmacy

Breach

8/2025

PRO1774989199

Loading…

A.I.

Proxycare Pharmacy Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Proxycare Pharmacy

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Proxycare Pharmacy in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Proxycare Pharmacy in 2026.

Incident Types Proxycare Pharmacy vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Proxycare Pharmacy in 2026.

Incident History - Proxycare Pharmacy (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Proxycare Pharmacy Subsidiaries

Parent Company

Proxycare Pharmacy

Pharmaceutical Manufacturing

Website: http://proxycarerx.com

Company Size: 51-200 employees

No subsidiary data available for this company.

Loading…

Proxycare Pharmacy Similar Companies

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

Torrent Pharmaceuticals Ltd

cb torrentpharma.com

Torrent Pharma, with annual revenues of more than Rs 10,700 crores, is the flagship Company of the Torrent Group, with group revenues of Rs 41,000 crores. It is ranked 5th in the Indian Pharma Market and is among the Top 5 in the therapeutic segments of Cardiovascular (CV), Central Nervous System (CNS), Gastro-intestinal (GI), Vitamins Minerals Nutritionals (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynaecology, oncology and anti-infective segments. Torrent has 8 manufacturing facilities , of which 5 are USFDA approved. With R&D as the backbone for its growth in domestic & overseas market, it has invested significantly in R&D capabilities with state-of-the-art R&D infrastructure employing around 800 scientists. The acquisition of Elder Pharma's Indian branded business in 2013, Dermaceuticals business of Zyg Pharma in 2015, API plant of Glochem Industries in 2016, Women healthcare brands from Novartis and Unichem's Indian branded business along with its Sikkim Plant in 2017 strengthened Torrent Pharma's position in the Indian Pharma market. Torrent Pharma started international acquisitions in 2005 with entry into the German market. Today, the Company has presence in more than 50 countries and is ranked No. 1 among the Indian pharma Companies in Brazil and Germany. Torrent Pharma is committed towards “not just healthcare but lifecare.”

Intas Pharmaceuticals

intaspharma.com

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business. Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK. Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products. Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies. The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab. Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Loading…

NEWS

Proxycare Pharmacy CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

April 01, 2026 01:59 PM

Proxycare Data Breach Reported; Attorneys Investigating

Was your information compromised in the Proxycare data breach? Learn more about the security incident and how a class action lawsuit may...

Read Article

March 31, 2026 08:41 PM

ProxyCare Inc Data Breach Exposes Social Security numbers

ProxyCare Inc, a pharmacy services company headquartered in Sunrise, Florida, disclosed a data breach that the company first discovered on...

Read Article

March 31, 2026 08:21 PM

Proxycare Data Breach Lawsuit Investigation

If you were affected by the Proxycare data breach, you may be entitled to compensation.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-103047

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in The Wikimedia Foundation Mediawiki - CentralAuth extension allows Stored XSS. This issue affects Mediawiki - CentralAuth extension: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103046

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in Wikimedia Foundation MediaWiki - WikiLambda extension allows Stored XSS. This issue affects MediaWiki - WikiLambda extension: before 1.46.1.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103045

SUMMARY

Improper neutralization of input during web page generation ('cross-site scripting') vulnerability in The Wikimedia Foundation Mediawiki - Refreshed skin allows Stored XSS. This issue affects Mediawiki - Refreshed skin: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103044

SUMMARY

XML injection (aka blind XPath injection) vulnerability in The Wikimedia Foundation Mediawiki - EasyTimeline extension allows XML Injection. This issue affects Mediawiki - EasyTimeline extension: before 1.46.1, 1.45.5, 1.43.10.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: )

Impact Score

Exploitability

REFERENCES

CVE-2026-103043

SUMMARY

anchorme through 3.0.8 contains a regular expression denial of service vulnerability in the IPv6 host extraction regex due to catastrophic backtracking. Attackers can supply specially crafted input strings with repeated patterns to cause exponential regex engine backtracking, blocking the Node.js event loop and denying service to other requests.

Published

Date2026-09-29

Updated

Date2026-09-29

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

3.9

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Proxycare Pharmacy Vendor Cyber Rating & Cyber Score

Proxycare Pharmacy A.I CyberSecurity Scoring

Proxycare Pharmacy CyberSecurity News & History

Proxycare Pharmacy Company Scoring based on AI Models